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UNIT A1.7Rule Out (R/O) Migraine
When imaging patients with headaches, the goals are (1) to rule out a more ominous
etiology for their headaches and, when atypical or complicated migraine is suspected,
(2) to assess the degree of hemodynamic and parenchymal involvement. The standard
images allow other etiologies such as mass lesions to be excluded and an MR venogram
can rule out venous sinus thrombosis. Contrast may be helpful in differentiating multiple
small metastases, demylinating lesions with inflammatory components, and subcortical
infarcts from the nonspecific foci of increased T2 associated with migraines that do
not enhance. Perfusion-weighted imaging allows detection assessment of hemodynamic
compromise. Diffusion-weighted imaging, in combination with the standardMR images,
allows assessment of parenchymal involvement. The followingBasic Protocol can be used
for the evaluation of patients. TheAlternate Protocol is used for the assessment of cerebral
perfusion in patients with visual auras.
BASIC
PROTOCOL
STANDARD IMAGING FOR MIGRAINE
In order to perform the optional sequences, perfusion and diffusion studies, a scanner
with echoplanar capabilities is required (Table A1.7.1). The standard anatomical MR
imaging sequences included in the protocols do not require these faster gradients. The
parameters given here are optimized for a 1.5T GE LX system with 11.0 software and
may need modification for different software versions, field strengths, or manufacturers.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen. Reactions to contrast agents are rare, but the
resources are necessary.
Table A1.7.1 Equipment Requirements for Cerebral Vascular Assessment
Type of system LX EchoSpeed
Field strength 1.5 T
Software level 11
Magnet type CX K4
Polarity Positive
Active gradient shielding No
Passive gradient shielding No
Gradient strength (amplitude) 2.4 mT/cm
Slew rate 12 mgauss/cm
SAR (average) 2 W/kg
SAR (max) 8 W/kg
Superior conductive shimming 45 cm
Resistive shimming No
Active magnetic shielding No
Maximum noise level 100 db
Type of body coil High pass
TPS recon system memory 386
Array processor (TPS) Reflex 100
Computer LX Octane
Weight limit 350 lb (130.6 kg)
Contributed by Steven Thibodeau and Ellen Grant
Current Protocols in Magnetic Resonance Imaging (2005) A1.7.1-A1.7.11
Copyright C© 2005 by John Wiley & Sons, Inc.
Intracranial
Arterial Disease
A1.7.1
Supplement 13
Rule Out (R/O)
Migraine
A1.7.2
Supplement 13 Current Protocols in Magnetic Resonance Imaging
Materials
Gadolinium-DTPA contrast agent (e.g., Magnevist, Omniscan, Prohance)
Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no counterindications such
as cardiac pacemakers or other implants containing ferromagnetic materials. Also be
sure to find out if the patient has any health conditions that may require the presence
of special emergency equipment during the scanning procedure, or necessitate any
other precautions. Do not forget to ask if the patient has any drug allergies and
document them.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system (see APPENDIX 1).
The presence of any ferromagnetic metals may be a health hazard to the patient when
he or she is inside the magnet, and will also affect the imaging. If in doubt as to the
exact composition of the items, it is best to exclude patients with any metal implants; see
Shellock (1996) for discussion of what implants may be safely scanned using magnetic
resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be
able to communicate with the technologist at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results, the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Have the patient mount onto the table. Either before or right after the patient lies
down, set up any triggering devices or other monitoring equipment that is to be used.
7. Center the patient in a head or neck coil at the region where the key information
is desired. Make sure that the head and neck are constrained to prevent motion,
especially if high-resolution scans are to be run.
Generally the patient’s head is fixed so that the head is horizontal (not tilted) and the
neck and head lie along the axis of the patient table; other positions may be appropriate
depending on the needs at hand.
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Table A1.7.2 Rapid Sagittal T1-Weighted Scout
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal
Central slice or volume center Nasion
Echo time (TE) Minimum (at least 4.1msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 100 msec
Flip angle (FA) 60◦
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (x, y) 0.94 mm, 1.87 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (z) 7 mm
Number of slices 7
Slice gap 2 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Scan time 16 sec
8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Use the centering light to position the patient and put him or her into the center of
the magnet.
Once this step has been performed, so long as the patient does not move on the table,
the table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: Rapid sagittal T1-weighted scout
11. To determine the patient’s position, a fast sagittal scout scan is performed using the
imaging sequence in Table A1.7.2.
Some centers may prefer a rapid three-plane scout instead of this multislice sagittal scout.
Sequence 2: Transverse FLAIR
12. From the sagittal scout, select the image through the center of the brain to set up
the locations for the transverse FLAIR. The locations should be the same as those
chosen for the transverse diffusion. Set up the imaging parameters as shown in Table
A1.7.3.
13. Warn the patient that this sequence is starting and begin the scan.
Sequence 3: Transverse T2-weighted FSE
14. From the sagittal scout, select the image through the center of the brain to set up
the locations for the transverse T2 FSE. The locations should be the same as those
chosen for the transverse diffusion. Set up the imaging parameters as shown in Table
A1.7.4.
15. Warn the patient that this sequence is starting and begin the scan.
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Table A1.7.3 Transverse FLAIR
Patient position Supine
Scan type Inversion recovery FSE
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 120 msec
Receiver bandwidth (RBW) 20.83 kHz
Repeat time (TR) 10,000 msec
Inversion time (TI) 2200 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (x, y) 0.86 mm, 1.14 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Saturation pulses Inferior
Scan time 4 min, 44 sec
Table A1.7.4 Transverse T2-Weighted FSE
Patient position Supine
Scan type Fast spin echo XL
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) FSE-XL
Central slice or volume center Nasion
Echo time (TE) 102 msec
Receiver bandwidth (RBW) 11.36 kHz
Echo train length (ETL) or shots (SH) 12
Repeat time (TR) 6000 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 0.86 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 320, 256
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 2
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Flow compensation Yes
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Scan time 3 min, 19 sec
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Table A1.7.5 Transverse Diffusion
Patient position Supine
Scan type SE-EPI
Imaging plane (orientation) Transverse
Central slice or volume center Nasion
Echo time (TE) Minimum (80.9 msec)
Echo train length (ETL) or shots (SH) 1 SH
Repeat time (TR) 5000 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (x, y) 1.72 mm, 1.72 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 3
Number of acquisitions (Nacq) 1
Read direction Right–left
Saturation pulses Fat saturation (automatic with EPI)
Control variables (CV) Ramp sampling = 1,
burst sampling = 0
b-value 1000 sec/min2
Direction 6
Scan time 3 min, 5 sec
Sequence 4: Transverse diffusion
16. From the sagittal scout, select the image through the center of the brain to set up
the locations for the transverse diffusion. The transverse images should begin at the
foramenmagnum and end at the top of the brain. Set up imaging parameters as shown
in Table A1.7.5.
17. Warn the patient that this sequence results in loud beeping noises and begin the scan.
Most diffusion sequenceswill performaminimumof four sequences: threewith orthogonal
diffusion gradient directions and one with a minimal or no diffusion gradient. Often, a fifth
set of images is also provided, which combines the three orthogonal gradient images to
produce a set of imageswhose signal intensity is not affected by the diffusion direction. This
is the DWI. In order to obtain apparent diffusion coefficient (ADC) maps, the images may
need further processing. On aGE system, the ADCmaps can be obtained by processing on
the Advantage Window Workstation using FuncTool version 3.1P using FuncTool version
1.9M.
Sequence 5: Coronal 2-D TOF MR venogram (optional)
18. From the sagittal scout, select the image through the center of the brain to set up the
locations for the coronal TOF MR venogram. The entire brain should be included.
Set up the imaging parameters as shown in Table A1.7.6.
19. Warn the patient that this sequence is starting and begin the scan.
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Table A1.7.6 Coronal 2-D TOF MR Venogram
Patient position Supine
Scan type Vascular TOF SPGR
Imaging plane (orientation) Coronal
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) Minimum
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 40 msec
Flip angle (FA) 60◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86, 1.14
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 1.5 mm
Number of slices Variable (depends on area of
coverage)
Slice gap 0
Number of excitations (NEX) 1
Number of acquisitions (Nacq) Variable (depends on area of
coverage)
Read direction Superior–Inferior
Saturation pulses Inferior
Scan time 12 sec/slice
Sequence 6: Transverse T1-weighted spin echo (optional)
20. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse T1. The locations should be the same as those chosen for
the transverse diffusion. Set up the imaging parameters as shown in Table A1.7.7.
21. Warn the patient that this sequence is starting and begin the scan.
Sequence 7: Transverse post-contrast T1-weighted spin echo (optional)
22. Using a small-gauge butterfly, inject a single dose of contrast by weight (usually
20 ml) intravenously.
23. From the sagittal scout, select the image through the center of the brain to set up
the locations for the post-contrast transverse T1. The locations should be the same
as those chosen for the transverse precontrast T1. Set up the imaging parameters as
shown in Table A1.7.8.
24. Warn the patient that this sequence is starting and begin the scan.
Sequence 8: Coronal post-contrast T1-weighted spin echo (optional)
Contrastmay be helpful in differentiatingmultiple smallmetastases, demylinating lesions
with inflammatory components, and subcortical infarcts from the nonspecific foci of
increased T2 associated with migraines that do not enhance.
25. From the sagittal scout, select the image through the center of the brain to set up the
locations for the coronal post-contrast T1. Set up the imaging parameters as shown
in Table A1.7.9.
26. Warn the patient that this sequence is starting and begin the scan.
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Table A1.7.7 Transverse T1-Weighted Spin Echo
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) Minimum full (14 msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 400 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 1.14 mm
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Flow compensation No
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Scan time 2 min, 8 sec
Table A1.7.8 Transverse Post-Contrast T1-Weighted Spin Echo
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) Minimum full (20 msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 400 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 1.14 mm
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Flow compensation Yes
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Scan time 2 min, 8 sec
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Table A1.7.9 Coronal Post-Contrast T1-Weighted Spin Echo
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) Minimum full (20 msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 1.14 mm
Number of data points collected (Nx, Ny) 256, 144
Display matrix (Dx, Dy) 256, 192
Slice thickness (z) 5 mm
Number of slices 26
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Superior–inferior
Flow compensation Yes
Extended dynamic range (EDR) Yes
Saturation pulses Inferior
Scan time 2 min, 40 sec
ALTERNATE
PROTOCOL
ASSESSMENT OF CEREBRAL PERFUSION IN PATIENTS WITH AURAS
Occasionally perfusion weighted imaging may be helpful in patients with migraine to as-
sess for associated perfusion changes. During the aura and the first few hours of headache
transient hypoperfusion has been documented whereas others have noted hyperfusion but
this may occur at a later phase. Although still controversial, perfusion differences in the
setting of migraine do not typically respect vascular territories which help differentiate
these changes from stroke related changes.
Materials
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, Prohance)
Normal saline (0.9% NaCl), sterile
18-G angiocatheter and MR-compatible injection pump
Set up patient and equipment
1. Set up patient and equipment as described in Basic Protocol, steps 1 to 10.
2. Establish an intravenous line using an 18-G angiocatheter through which the contrast
agent can be injected. Attach this line securely to the patient so that movement into
or out of the magnet will not pull at the patients arm.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet, so
that there is no intervening motion between the scans run before contrast agent injection
and those run after injection.
3. Connect the MR-compatible injection pump, cleared of air, and loaded with a double
dose of contrast agent and saline flush, to the patient. Do a small test injection of
normal saline to ensure that the i.v. is working properly.
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Table A1.7.10 Transverse Perfusion
Patient position Supine
Scan type GRE-EPI
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 54 msec
Echo train length (ETL) or shots (SH) 1
Repeat time (TR) 1500 msec
Flip angle (FA) 35◦
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (x, y) 1.72 mm, 1.72 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Right–left
Slice location Inferior slice to include MCA
Slice series Interleaved
Control variables (CV) Ramp sampling = on,
burst sampling = off
Multiphase Yes, 46 phases per location,
minimum delay between acquisition
Scan time 1 min, 10 sec
4. Program a 5 ml/sec injection rate for both contrast and saline, the contrast dose
required (double dose by weight), the saline flush required (typically 40 ml), and a
10-sec time delay. Start the saline running at TKVO (to keep vein open) and arm the
injection pump.
Sequences 1 to 5
5. Perform sequences 1 to 4 and sequence 6 as described in the Basic Protocol.
Sequence 6: Transverse perfusion
6. Using the transverse T2-weighted FSE images, find the slice location where the
middle cerebral arteries are best seen. Using the imaging parameters as shown in
Table A1.7.10, set up the transverse images starting at the same location where the
MCA were identified on the T2 FSE. Typically only ten or eleven slices can be
obtained in the given TR interval. The slice thickness and gap can be modified so that
the perfusion study covers any diffusion abnormality.
7. Check that the injection pump is ready to inject and that the injection is set to start
after a 10-sec delay.
8. Warn the patient that this sequence is starting and that, partway through the scan, the
i.v. injection will occur. Begin the scan.
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Data processing and viewing for Sequence 6
9. Process the perfusion images using an appropriate workstation and software to give
maps of relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF),
and mean transit time (MTT).
On a GE system, one can use an Advantage Windows Workstation with FuncTool version
1.9M.
Sequences 7 and 8
10. Perform sequences 7 and 8 as described in the Basic Protocol.
COMMENTARY
Background Information
The incidence of small foci of increased T2
signal in patients with a history of migraine
varies from study to study. Reported incidence
rates vary from 13% to 39.6% for migraineurs,
dropping to 5.5% to 29.4% for those under 40
compared to the range of 4.3% to 11.2% for
controls (Igarashi et al., 1991; Osborn et al.,
1991; Robbins and Friedman, 1992; Pavese
et al., 1994; De Benedittis et al., 1995; Cooney
et al., 1996). Other causes of focal T2 hyper-
intensities that should be ruled out include hy-
pertension, athlerosclerotic heart disease, dia-
betes mellitus, autoimmune disorders, and de-
myelinating diseases. The increased frequency
of T2 hyperintensities in pediatric migraineurs
is controversial, with some stating there is no
increase in incidence (McAbee et al., 1993)
and others reporting a 50% incidence vs. 17%
for age-matched controls (Hamalainen et al.,
1996). Perfusion changes have been detected
during visual auras with these changes persist-
ing for 2.5 hr into the migraine. These perfu-
sion studies showed decreased cerebral blood
flow (16% to 53%), decreased cerebral blood
volume (6% to 33%), and increased tissue
mean transit time (10% to 54%) in the gray
matter of the occipital cortex (Cutrer et al.,
1998). Migraines without aura showed no sig-
nificant hemodynamic changes (Sanchez del
Rio et al., 1999). Rarely, as in the case of basi-
lar arterymigraine, reversible cortical swelling
may be seen (Maytal et al., 1998). Hemiplegic
migraine also has uncommon findingswith de-
creased diffusion, decreased blood flow, and
leptomeningeal enhancement reported (Craw-
ford and Konkol, 1997, Arnold et al., 1998,
Chabriat et al., 2000). In a similar group of pa-
tients with visually triggered migraines, neu-
ronal suppression was accompanied by base-
line contrast intensity increases on functional
MRI that suggested vasodilatation and tissue
hyperoxygenation.
Critical Parameters and
Troubleshooting
For a discussion of critical parameters and
troubleshooting, see UNITS A1.1 & A1.2, as well
as UNITS A1.5 & A1.6.
Anticipated Results
In most cases, the imaging studies in pa-
tients with migraines will be normal or show
nonspecific foci of increased T2 signal that
are typically more prominent in the frontal re-
gions. It is prudent, however, to rule out other
potential causes ofmultiple fociwith increased
T2 signal such as hypertension, athlerosclerotic
heart disease, diabetes mellitus, autoimmune
disorders, or demyelinating diseases.
In patients with basilar artery migraine,
hemiplegic migraine, or visually triggered mi-
graines, other imaging findings (see Back-
ground Information) may be observed.
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